Cyllene Therapeutics
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
€33MSeries C
Role not disclosedGG
GordonMD Global Investments
Activity from announced rounds
Activity in this selectionpareto-20-cd7055b6
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $57.7M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionRapalogix Health
Develops prescription therapeutics and skincare products for cellular longevity and skin health
$20MSeries A
Role not disclosed